Skip to main content
Trending:
New GA Law Divides Providers
Podcast: Tech and the Bottom Line
UHC PA Mandate Roils GIs
Toggle navigation
Topics
Pharma
Post-Acute
Technology
Telehealth
Clinical Care
Payer
Strategy
Finance
Revenue Cycle
Innovation
Nursing
Human Resources
Marketing
Supply Chain
COVID-19
Events
Resources
Weekly Wrap Video
HLM Podcasts
Free Webinars
HealthLeaders Magazine
Whitepapers
Fact File
Intelligence Reports
Profile Reports
Exchange Insight Reports
Industry Focus Reports
Roundtable Reports
One Minute Matters Videos
Subscribe
Search form
Enter search term
Pharma
PBMs, the Brokers Who Control Drug Prices, Finally Get Washington's Attention
After years of thundering against drugmakers, Congress and the administration have now focused on regulating PBMs.
A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
The suit marks the first time since 2009 that the FTC has tried to block a drug company merger.
AHIP, PhRMA Swap Blame for High Healthcare Costs
The nation's big drug and health insurance lobbies are blaming each other for rising healthcare costs.
Get the latest on healthcare leadership in your inbox.
Subscribe
Advertisement
Lawyer's Rezolute on track for late-stage studies for hypoglycemia and diabetic macular edema treatments
As an advisor to hundreds of therapeutic and tech startups over the years, this innovator observed both good and bad...
Should a Pharmacist Be Allowed to Deliver Primary Care Services?
A HIMSS 2023 panel debated whether pharmacists could help beleaguered primary care doctors by taking on some non-acute care services.
After Pandemic Delays, FDA Still Struggling to Inspect Foreign Drug Manufacturers
A ProPublica analysis of FDA data reveals that the agency only inspected 6% of the overseas plants where drugs and...
Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Competition to claim a $100 billion market for drugmakers has triggered a wave of advertising that has provoked public health...
The Drug Company that Prospered Without Creating Any Drugs
Horizon says it has 20 drugs under development, in its 15 years of existence it has yet to license a...
Most Payers Use Outcomes-Based Contracts for Drugs
Over 35% of surveyed health plans said they used more than 10 outcomes-based contracts (OBCs) in the plan year 2022.
Walgreens is set to layoff more than 500 workers - 10% of its corporate workforce
Walgreens Boots Alliance is to layoff 504 corporate employees as financial obligations for opioid litigation and other legal matters pile...
STING like a bee: MIT’s revolutionary approach to cancer immunotherapy
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
Physician group challenges FDA action to restrict use of COVID-19 medication
After the FDA issued an emergency use authorization (EUA) for a COVID-19 drug but limited its use to hospital inpatients,...
No end in sight for the legal dispute between UMass Memorial and UMass Chan Medical School
UMass Memorial Medical Center and the UMass Chan Medical School have been locked in a bitter legal dispute over the...
COVID kills one person every four minutes as vaccine rates fall
COVID is still killing at least one person every four minutes and questions on how to deal with the virus...
Chicago mpox outbreak raises alarm over summer spread
A cluster of mpox cases in the Chicago area has spurred concerns of a resurgence this summer, mere months after...
Load More